1. Merck Patent Gmbh (9 from 2,937 patents)

2. Centre National De La Recherche Scientifique (2 from 5,069 patents)

3. Institut National De La Sante Et De La Recherche Medicale (2 from 1,743 patents)

4. Merck Patent Gesellschaft MIT Beschrankter Haftung (2 from 1,248 patents)

5. Universite Claude Bernard – Lyon1 (2 from 208 patents)

6. Poxel (2 from 13 patents)

7. Ens-ecole Normale Superieure De Lyon (2 from 4 patents)

8. Edelris (2 from 2 patents)

9. Bayer Pharma Aktiengesellschaft (1 from 378 patents)

10. Merck Patent Gesellschaft (1 from 121 patents)

11. Mellitech (1 from 1 patent)

12. Merk Patent Gmbh (3 patents)

1. 10654818 - Furane derivatives as inhibitors of ATAD2

2. 10071108 - Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection

3. 9895380 - Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection

4. 8765728 - [1,5]-diazocin derivatives

5. 8586577 - Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors

6. 8575161 - Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators

7. 8546575 - NIP thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydroge-nase-1

8. 8486964 - Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors

9. 8470849 - 7-azaindole derivatives as selective 11-β-hydroxysteroid dehydrogenase type 1 inhibitors

10. 8466200 - 2-adamantylurea derivatives as selective 11β-HSD1 inhibitors

11. 8242107 - Diazepane-acetamide derivatives as selective 11β-HSD1 inhibitors

12. 8188288 - 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors

13. 8183265 - 2-adamantyl-butyramide derivatives as selective 11β-HSD1 inhibitors

14. 7754740 - [object Object]

15. 7582656 - Guanidine derivatives and therapeutic uses thereof